Stage 6 Harmonization
Official December 1, 2011 905 Uniformity of Dosage Units 1
The test for Content Uniformity is required for all dosage
905 UNIFORMITY OF DOSAGE forms not meeting the above conditions for the
Weight
Variation test.
1
2S (USP34)
UNITS
Table 1. Application of Content Uniformity (CU) and Weight
Variation (WV) Tests for Dosage Forms
Dose & Ratio of
Drug Substance
Change to read:
25 <25
mg mg or
This general chapter is harmonized with the correspond-
and <25%Dosage
ing texts of the European Pharmacopoeia and the Japanese
25%Form Type Subtype
Pharmacopoeia. Portions of the general chapter text that are
national USP text, and are not part of the harmonized text, Uncoated WV CUTablets
are marked with symbols (
) to specify this fact.
Film WV CU
N
OTE
In this chapter, unit and dosage unit are
Others CU CUCoated
synonymous.
Hard WV CUCapsules
To ensure the consistency of dosage units, each unit in a
Suspension,
batch should have a drug substance content within a nar-
emulsion,
row range around the label claim. Dosage units are defined
or gel CU CU
as dosage forms containing a single dose or a part of a dose
Solutions WV WVSoft
of drug substance in each unit. The uniformity of dosage
units specification is not intended to apply to suspensions, Single com-Solids in sin-
emulsions, or gels in unit-dose containers intended for ex- ponent WV WVgle-unit
ternal, cutaneous administration. containers
Solution
The term “uniformity of dosage unit” is defined as the
freeze-
degree of uniformity in the amount of the drug substance
dried in fi-
among dosage units. Therefore, the requirements of this
nal
Multiple
chapter apply to each drug substance being comprised in
container WV WV
compo-
dosage units containing one or more drug substances, un-
Others CU CUnents
less otherwise specified elsewhere in this Pharmacopeia.
Solutions in
The uniformity of dosage units can be demonstrated by
unit-dose
either of two methods, Content Uniformity or
Weight
Varia-
containers
tion (see Table 1). The test for Content Uniformity of prepa-
and into
rations presented in dosage units is based on the assay of
soft cap-
the individual content of drug substance(s) in a number of
sules
WV WV
dosage units to determine whether the individual content is
Others CU CU
within the limits set. The Content Uniformity method may be
applied in all cases.
The test for
Weight
Variation is applicable for the follow-
ing dosage forms:
Change to read:
(W1) Solutions enclosed in unit-dose containers and into soft
capsules;
CONTENT UNIFORMITY
(W2) Solids (including powders, granules, and sterile solids)
that are packaged in single-unit containers and contain
Select not fewer than 30 units, and proceed as follows for
no active or inactive added substances;
the dosage form designated.
(W3) Solids (including sterile solids) that are packaged in sin-
Where different procedures are used for assay of the prep-
gle-unit containers, with or without active or inactive
aration and for the Content Uniformity test, it may be neces-
added substances, that have been prepared from true
sary to establish a correction factor to be applied to the
solutions and freeze-dried in the final containers and are
results of the latter.
labeled to indicate this method of preparation; and
Solid Dosage Forms—Assay 10 units individually using
(W4) Hard capsules, uncoated tablets, or film-coated tablets,
an appropriate analytical method. Calculate the acceptance
containing 25 mg or more of a drug substance compris-
value (see Table 2).
ing 25% or more, by weight, of the dosage unit or, in
Liquid
or Semi-Solid
2S (USP34)
Dosage Forms—
Assay 10
the case of hard capsules, the capsule contents, except
units individually using an appropriate analytical
that uniformity of other drug substances present in
method.
2S (USP34)
Carry out the assay on the amount of well-
lesser proportions is demonstrated by meeting the re-
mixed material that is removed from an individual container
quirements for Content Uniformity.
1
European Pharmacopoeia and Japanese Pharmacopoeia text not accepted
by the United States Pharmacopeia: Alternatively, products listed in item (4)
above that do not meet the 25 mg/25% threshold limit may be tested for
uniformity of dosage units by Mass Variation instead of the Content Uniform-
ity test if the concentration relative standard deviation (RSD) of the drug
substance in the final dosage units is not more than 2%, based on process
validation data and development data, and if there has been regulatory ap-
proval of such a change. The concentration RSD is the RSD of the concentra-
tion per dosage unit ( w/w or w/v), where concentration per dosage unit
equals the assay result per dosage unit divided by the individual dosage unit
weight. See the RSD formula in Table 2.
✦■2S (USP34)
2011 The United States Pharmacopeial Convention All Rights Reserved.
Stage 6 Harmonization
2 905 Uniformity of Dosage Units Official December 1, 2011
in conditions of normal use, and express the results as de- in which the terms are as defined in Table 2.
livered dose. Calculate the acceptance value (see Table 2).
Calculation of Acceptance Value—Calculate the accep-
tance value by the formula:
Table 2
Variable Definition Conditions Value
Mean of individual contents (χ
1
,
χ
2
, , χ
n
), expressed as a per-
X centage of the label claim
χ
1
, χ
2
, , χ
n
Individual contents of the units
tested, expressed as a percentage
of the label claim
n Sample size (number of units in a
sample)
If n = 10, then k = 2.4k Acceptability constant
If n = 30, then k = 2.0
s Sample standard deviation
RSD Relative standard deviation (the 100s/X
sample standard deviation ex-
pressed as a percentage of the
mean)
If 98.5% X 101.5%, then M = X (AV = ks)M (case 1) to be applied when T Reference value
101.5
M = 98.5%
If X <98.5%, then (AV = 98.5 – X + ks)
M = 101.5%
If X >101.5%, then (AV = X – 101.5 + ks)
M = XM (case 2) to be applied when T Reference value
If 98.5 X T, then
(AV = ks)>101.5
M = 98.5%
If X <98.5%, then
(AV = 98.5 – X + ks)
M = T%
If X >T, then (AV = X – T + ks)
Acceptance value (AV) general formula:
(Calculations are specified above
for the different cases.)
L1 Maximum allowed acceptance L1 = 15.0 unless otherwise speci-
value fied
2011 The United States Pharmacopeial Convention All Rights Reserved.
Stage 6 Harmonization
Official December 1, 2011 905 Uniformity of Dosage Units 3
Table 2 (Continued)
Variable Definition Conditions Value
L2 Maximum allowed range for On the low side, no dosage unit L2 = 25.0 unless otherwise speci-
deviation of each dosage unit result can be less than fied
tested from the calculated value [1–(0.01)(L2)]M, while on the
of M high side no dosage unit result
can be greater than [1 +
(0.01)(L2)]M. (This is based on
an L2 value of 25.0.)
T Target content per dosage unit at
the time of manufacture, ex-
pressed as a percentage of the
label claim.
Unless otherwise
stated, T is 100.0 per cent, or T
is the manufacturer’s approved
target content per dosage
unit.
2S (USP34)
Liquid Dosage Forms—Accurately weigh the amount of
liquid that is removed from each of 10 individual containers
in conditions of normal use. If necessary, compute the
WEIGHT
VARIATION
equivalent volume after determining the density. Calculate
the drug substance content in each container from the mass
Carry out an assay for the drug substance(s) on a repre-
of product removed from the individual containers and the
sentative sample of the batch using an appropriate analyti-
result of the assay. Calculate the acceptance value.
cal method. This value is result A, expressed as percent of
label claim (see Calculation of Acceptance Value). Assume that Calculation of Acceptance Value—Calculate the accep-
the concentration (weight of drug substance per weight of tance value as shown in Content Uniformity, except that the
dosage unit) is uniform. Select not fewer than 30 dosage individual contents of the units are replaced with the indi-
units, and proceed as follows for the dosage form vidual estimated contents defined below.
designated.
Uncoated or Film-Coated Tablets—Accurately weigh 10
χ
1
, χ
2
, ... , χ
n
= individual estimated contents of the units
tablets individually. Calculate the content, expressed as %
tested, where χ
i
= w
i
× A/W
of label claim, of each tablet from the
weight
of the indi-
w
1
, w
2
, ... , w
n
= individual
weights
of the units tested
vidual tablet and the result of the Assay. Calculate the ac-
A = content of drug substance (% of label claim)
ceptance value.
obtained using an appropriate analytical
Hard Capsules—Accurately weigh 10 capsules individu-
method
ally, taking care to preserve the identity of each capsule.
W = mean of individual
weights
Remove the contents of each capsule by a suitable means.
(w
1
, w
2
, ,w
n
)
Accurately weigh the emptied shells individually, and calcu-
late for each capsule the net
weight
of its contents by
subtracting the
weight
of the shell from the respective
gross
weight
. Calculate the drug substance content of
Change to read:
each capsule from the
net weight
of the individual cap-
sule
content
and the result of the Assay. Calculate the
acceptance value.
Soft Capsules—Accurately weigh 10 intact capsules indi-
CRITERIA
vidually to obtain their gross
weights
, taking care to pre-
serve the identity of each capsule. Then cut open the cap-
Apply the following criteria, unless otherwise specified.
sules by means of a suitable clean, dry cutting instrument
Solid,
Semi-Solid,
2S (USP34)
and Liquid Dosage Forms
such as scissors or a sharp open blade, and remove the
The requirements for dosage uniformity are met if the ac-
contents by washing with a suitable solvent. Allow the oc-
ceptance value of the first 10 dosage units is less than or
cluded solvent to evaporate from the shells at room temper-
equal to L1%. If the acceptance value is > L1%, test the
ature over a period of about 30 minutes, taking precautions
next 20 units, and calculate the acceptance value. The re-
to avoid uptake or loss of moisture. Weigh the individual
quirements are met if the final acceptance value of the 30
shells, and calculate the net contents. Calculate the drug
dosage units is L1%, and no individual content of
any
substance content in each capsule from the
weight
of
dosage unit is less than [1 (0.01)(L2)]M nor more than [1
product removed from the individual capsules and the result
+ (0.01)(L2)]M
as specified
in the Calculation of Acceptance
of the assay. Calculate the acceptance value.
Value under Content Uniformity or under
Weight
Variation.
Solid Dosage Forms Other Than Tablets and
Unless otherwise specified, L1 is 15.0 and L2 is 25.0.
Capsules—Proceed as directed for Hard Capsules, treating
each unit as described therein. Calculate the acceptance
value.
2011 The United States Pharmacopeial Convention All Rights Reserved.